2.09
price down icon0.48%   -0.01
 
loading

Finanzdaten der Hillevax Inc-Aktie (HLVX)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
8.14%
6.985
7.604 36.15 26.38 42.96
Operating Income/Loss
8.14%
-6.985
-7.604 -36.15 -26.38 -42.96
Nonoperating Income/Loss
11.41%
1.719
1.543 2.204 0.557 2.295
Income/Loss From Continuing Operations Before Tax
13.12%
-5.266
-6.061 -33.95 -25.82 -40.67
Income/Loss From Continuing Operations After Tax
13.12%
-5.266
-6.061 -33.95 -25.82 -40.67
Net Income/Loss
13.12%
-5.266
-6.061 -33.95 -25.82 -40.67
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.27%
50.11
49.98 0.1445 49.38 49.18
Diluted Average Shares
0.27%
50.11
49.98 0.1445 49.38 49.18
Basic Earnings Per Share
8.33%
-0.11
-0.12 -0.69 -0.52 -0.83
Diluted Earnings Per Share
8.33%
-0.11
-0.12 -0.69 -0.52 -0.83
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$35.42
price up icon 0.77%
$83.90
price up icon 0.91%
$28.24
price up icon 0.89%
$99.26
price up icon 1.41%
$144.75
price up icon 1.12%
biotechnology ONC
$327.20
price down icon 1.53%
Kapitalisierung:     |  Volumen (24h):